Assessment and evaluation of the high risk neonate: the NICU Network Neurobehavioral Scale

Barry M Lester, Lynne Andreozzi-Fontaine, Edward Tronick, Rosemarie Bigsby, Barry M Lester, Lynne Andreozzi-Fontaine, Edward Tronick, Rosemarie Bigsby

Abstract

There has been a long-standing interest in the assessment of the neurobehavioral integrity of the newborn infant. The NICU Network Neurobehavioral Scale (NNNS) was developed as an assessment for the at-risk infant. These are infants who are at increased risk for poor developmental outcome because of insults during prenatal development, such as substance exposure or prematurity or factors such as poverty, poor nutrition or lack of prenatal care that can have adverse effects on the intrauterine environment and affect the developing fetus. The NNNS assesses the full range of infant neurobehavioral performance including neurological integrity, behavioral functioning, and signs of stress/abstinence. The NNNS is a noninvasive neonatal assessment tool with demonstrated validity as a predictor, not only of medical outcomes such as cerebral palsy diagnosis, neurological abnormalities, and diseases with risks to the brain, but also of developmental outcomes such as mental and motor functioning, behavior problems, school readiness, and IQ. The NNNS can identify infants at high risk for abnormal developmental outcome and is an important clinical tool that enables medical researchers and health practitioners to identify these infants and develop intervention programs to optimize the development of these infants as early as possible. The video shows the NNNS procedures, shows examples of normal and abnormal performance and the various clinical populations in which the exam can be used.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4828009/bin/jove-90-3368-thumb.jpg

References

    1. Lester BM, Tronick EZ. The NICU Network Neurobehavioral Scale (NNNS) Pediatrics (Supplement) 2004;113:631–699.
    1. Prechtl HF. The behavioural states of the newborn infant (a review) Brain Res. 1974;76(2):185–212.
    1. Saint-Anne Dargassies S. Neurological Development in the Full-Term and Premature Neonate. New York, NY: Elsevier North Holland; 1977.
    1. Brazelton TB. Neonatal behavior assessment scale. 2. Spastics International Medical Publications; 1984.
    1. Finnegan L. Neonatal abstinence syndrome: Assessment and pharmacotherapy. In: Rubatelli F, Granata B, editors. Neonatal therapy and update. New York: Experta Medica; 1986.
    1. Tronick EZ, Olson K, Rosenberg R, Bohne L, Lu J, Lester BM. Normative neurobehavioral performance of healthy infants on the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3 Pt 2):676–678.
    1. Fink NS, Tronick E, Olson K, Lester B. Healthy newborns' neurobehavior: norms and relations to medical and demographic factors. J Pediatr. 2012;161(6):1073–1079.
    1. Liu J, Bann C, Lester B, et al. Neonatal neurobehavior predicts medical and behavioral outcome. Pediatrics. 2010;125(1):90–98.
    1. Sucharew H, Khoury JC, Xu Y, Succop P, Yolton K. NICU Network Neurobehavioral Scale profiles predict developmental outcomes in a low-risk sample. Paediatric and perinatal epidemiology. 2012;26(4):344–352.
    1. Lesseur C, Armstrong DA, Murphy MA, et al. Sex-specific associations between placental leptin promoter DNA methylation and infant neurobehavior. Psychoneuroendocrinology. 2014;40:1–9.
    1. Lester BM, Tronick EZ, LaGasse L, et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics. 2002;110(6):1182–1192.
    1. Napiorkowski B, Lester BM, Freier MC, et al. Effects of in utero substance exposure on infant neurobehavior. Pediatrics. 1996;98(1):71–75.
    1. Smith LM, Lagasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol. 2008;30(1):20–28.
    1. LaGasse LL, Wouldes T, Newman E, et al. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol. 2011;33(1):166–175.
    1. de Moraes Barros MC, Guinsburg R, de Araujo Peres C, Mitsuhiro S, Chalem E, Laranjeira RR. Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. J Pediatr. 2006;149(6):781–787.
    1. Law KL, Stroud LR, LaGasse LL, Niaura R, Liu J, Lester BM. Smoking during pregnancy and newborn neurobehavior. Pediatrics. 2003;111(6):1318–1323.
    1. Stroud LR, Paster RL, Papandonatos GD, et al. Maternal smoking during pregnancy and newborn neurobehavior: effects at 10 to 27 days. J Pediatr. 2009;154(1):10–16.
    1. Yolton K, Khoury J, Xu Y, et al. Low-level prenatal exposure to nicotine and infant neurobehavior. Neurotoxicol Teratol. 2009;31(6):356–363.
    1. Barros MC, Mitsuhiro SS, Chalem E, Laranjeira RR, Guinsburg R. Prenatal tobacco exposure is related to neurobehavioral modifications in infants of adolescent mothers. Clinic. (Sao Paulo, Brazil) 2011;66(9):1597–1603.
    1. Conradt E, Sheinkopf SJ, Lester BM, et al. Prenatal substance exposure: neurobiologic organization at 1 month. J Pediatr. 2013;163(4):989–994.
    1. Yolton K, Xu Y, Strauss D, Altaye M, Calafat AM, Khoury J. Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol. 2011;33(5):558–566.
    1. Velez ML, Jansson LM, Schroeder J, Williams E. Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr Res. 2009;66(6):704–709.
    1. Jones H, O’Grady K, Johnson R, Velez M, Jansson L. Infant Neurobehavior Following Prenatal Exposure to Methadone or Buprenorphine: Results From the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Subst Use Misuse. 2010;45(13):2244–2257.
    1. Coyle MG, Ferguson A, LaGasse L, Liu J, Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Archives of Disease in Childhood: Fetal Neonatal Edition. 2005;90(1):F73–F74.
    1. Salisbury AL, Lester BM, Seifer R, et al. Prenatal cocaine use and maternal depression: effects on infant neurobehavior. Neurotoxicol Teratol. 2007;29(3):331–340.
    1. Brown N, et al. Alterations in Neurobehavior at Term Reflect Differing Perinatal Exposures in Very Preterm Infants. Pediatrics. 2006;118(6):2461–2471.
    1. Montirosso R, Del Prete A, Cavallini A, Cozzi P. Neurobehavioral profile in a group of healthy preterm infants. Utilization of the NICU Network Neurobehavioral Scale (NNNS) Child Development & Disabilities - ESSAYS. 2009;3:1–21.
    1. Brown NC, Inder TE, Bear MJ, Hunt RW, Anderson PJ, Doyle LW. Neurobehavior at term and white and gray matter abnormalities in very preterm infants. J Pediatr. 2009;155(1):32–38.
    1. Montirosso R, Del Prete A, Bellu R, Tronick E, Borgatti R. Level of NICU quality of developmental care and neurobehavioral performance in very preterm infants. Pediatrics. 2012;129(5):e1129–e1137.
    1. Lester B, Miller R, Hawes K, et al. Infant Neurobehavioral Development. Seminars in Perinatology. 2011;35(1):8–19.
    1. El-Dib M, Massaro A, Glass P, Aly H. Neurobehavioral assessment as a predictor of neurodevelopmental outcome in preterm infants. J Perinatol. 2013;32:299–303.
    1. Stephens BE, Liu J, Lester B, et al. Neurobehavioral assessment predicts motor outcome in preterm infants. J Pediatr. 2010;156(3):366–371.
    1. Miller-Loncar C, Lester BM, Seifer R, et al. Predictors of motor development in children prenatally exposed to cocaine. Neurotoxicol Teratol. 2005;27(2):213–220.
    1. Lester BM, Bagner DM, Liu J, et al. Infant neurobehavioral dysregulation: behavior problems in children with prenatal substance exposure. Pediatrics. 2009;124(5):1355–1362.
    1. de Moraes Barros M, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira R. Neurobehavior of full-term small for gestational age newborn infants of adolescent mothers. J Pediatr (Rio J) 2008;84(3):217–223.
    1. Massaro AN, Glass P, Brown J, et al. Neurobehavioral abnormalities in newborns with congenital heart disease requiring open-heart surgery. J Pediatr. 2011;158(4):678–681.
    1. de Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR. Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early human development. 2008;84(5):281–287.
    1. Bromer C, Marsit CJ, Armstrong DA, Padbury JF, Lester B. Genetic and epigenetic variation of the glucocorticoid receptor (NR3C1) in placenta and infant neurobehavior. Developmental psychobiology. 2013;55(7):673–683.
    1. Maccani MA, Padbury JF, Lester BM, Knopik VS, Marsit CJ. Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res. 2013;74(3):272–278.
    1. Paquette AG, Lesseur C, Armstrong DA, et al. Placental HTR2A methylation is associated with infant neurobehavioral outcomes. Epigenetics. 2013;8(8):796–801.
    1. Marsit CJ, Lambertini L, Maccani MA, et al. Placenta-imprinted gene expression association of infant neurobehavior. J Pediatr. 2012;160(5):854–860.
    1. Marsit CJ, Maccani MA, Padbury JF, Lester BM. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PloS One. 2012;7(3):e33794.
    1. Conradt E, Lester BM, Appleton AA, Armstrong DA, Marsit CJ. The roles of DNA methylation of NR3C1 and 11beta-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior. Epigenetics. 2013;8(12):1321–1329.
    1. Lester BM, Conradt E, Marsit CJ. Are epigenetic changes in the intrauterine environment related to newborn neurobehavior? Epigenomics. 2014;6(2):175–178.
    1. Lester B, Tronick E, Nestler E, et al. Behavioral epigenetics. Ann NY Acad Sci. 2011;1226:14–33.
    1. Lester B, Marsit C, Bromer C. Behavioral Epigenetics and the Developmental Origins of Mental Health Disorders. In: Brandt K, Perry B, Seligman S, Tronick E, editors. Infant & Early Childhood Mental Health: Core Concepts and Clinical Practice. Washington, DC: American Psychiatric Publishing, Inc; 2013. pp. 161–173.
    1. Lester B, Conradt E, Marsit C. Epigenetic basis for the development of depression in children. Clinical Obstetrics and Gynecology. 2013;56(3):556–565.
    1. Xu Y, Yolton K, Khoury J. Earliest appropriate time for administering neurobehavioral assessment in newborn infants. Pediatrics. 2011;127(1):e69–e75.
    1. Salisbury A, Duncan-Fallone M, Lester BM. Neurobehavioral Assessment From Fetus To Infant. The NICU Network Neurobehavioral Scale and The Fetal Neurobehavior Coding Scale. Mental Retardation and Developmental Disabilities Research Reviews. 2005;11:14–20.
    1. Bagner DM, Sheinkopf SJ, Miller-Loncar C, et al. The effect of parenting stress on child behavior problems in high-risk children with prenatal drug exposure. Child Psychiatry Hum Dev. 2009;40(1):73–84.
    1. Desantis A, Harkins D, Tronick E, Kaplan E, Beeghly M. Exploring an integrative model of infant behavior: What is the relationship among temperament, sensory processing, and neurobehavioral measures? Infant Behav Dev. 2011;34(2):280–292.
    1. Sullivan MC, Miller RJ, Fontaine LA, Lester B. Refining Neurobehavioral Assessment of the High-Risk Infant Using the NICU Network Neurobehavioral Scale. J Obstet Gynecol Neonatal Nurs. 2012;41(1):17–23.
    1. Boukydis CF, Bigsby R, Lester BM. Clinical use of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3 Pt 2):679–689.
    1. Simeonsson R, Sharp M, et al. Developmental delay: Signs and symptoms. In: Hoekelman R, editor. PrimaryPediatricCare. 2nd. St. Louis: Mosby Co; 1992.
    1. Marks K, Glascoe FP, Aylward GP, Shevell MI, Lipkin PH, Squires JK. The thorny nature of predictive validity studies on screening tests for developmental-behavioral problems. Pediatrics. 2008;122(4):866–868.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi